Public Calendar: May 9-15, 2021
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Janet Woodcock, M.D., Acting Commissioner
Event Date: 05/11/2021
Location: Virtual
Subject: Listening Session with the Council for Responsible Nutrition
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Andrea Wong, Brian Wommack, Megan Olsen, Steve Mister (Council for Responsible Nutrition);
Event Date: 05/12/2021
Location: Virtual
Subject: Reagan-Udall Foundation for the Food and Drug Administration Annual Public Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, media, government, and other registered guests
Event Date: 05/12/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
Event Date: 05/13/2021
Location: Virtual
Subject: Updates on Pfizer Vaccine Emergency Use Authorization
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Stakeholders from healthcare organizations, local and state health officials
Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 05/12/2021
Location: Virtual
Subject: 2021 Virtual Food Safety Summit
FDA Participant/Group: N/A
Non FDA Participant/Group: Members from the food industry, academia, and federal, state, and local regulatory organizations
Event Date: 05/13/2021
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from across the consumer associations, and scientific and technical staff from industry
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Erica Jefferson, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 05/10/2021
Location: Virtual
Subject: University of Southern California (USC) / Children's Hospital Los Angeles (CHLA) Cell Therapy Program Seminar Series; Facilitating the Development of Cellular Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders
Event Date: 05/11/2021
Location: Washington, DC
Subject: Update from Federal Officials on Efforts to Combat COVID-19
FDA Participant/Group: N/A
Non FDA Participant/Group: Senate Health, Education, Labor and Pension (HELP) Committee members and staffs
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
Event Date: 05/11/2021
Location: Virtual
Subject: National Center for Toxicological Research (NCTR) Science Advisory Board
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, industry, and other government agencies
Official Name: Mark Raza, J.D., Acting Chief Counsel
No Significant Event